Los Angeles Capital Management’s Voyager Therapeutics VYGR Stock Holding History

Los Angeles Capital Management’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$130K	Buy	+37,180	New	+$141K	﹤0.01%	1283
2025 Q3	–	Sell	-16,180	Closed	-$50.3K	–	1554
2025 Q2	$50.3K	Buy	+16,180	New	+$52.2K	﹤0.01%	1304
2021 Q2	–	Sell	-60,228	Closed	-$284K	–	1680
2021 Q1	$284K	Sell	60,228 -45,895	-43%	-$313K	﹤0.01%	1449
2020 Q4	$759K	Sell	106,123 -17,215	-14%	-$165K	﹤0.01%	1047
2020 Q3	$1.32M	Buy	123,338 +2,783	+2%	+$32.7K	0.01%	713
2020 Q2	$1.52M	Buy	120,555 +33,598	+39%	+$391K	0.01%	702
2020 Q1	$796K	Buy	86,957 +37,497	+76%	+$430K	0.01%	768
2019 Q4	$690K	Buy	49,460 +36,770	+290%	+$534K	﹤0.01%	932
2019 Q3	$218K	Hold	12,690	–	–	﹤0.01%	1193
2019 Q2	$345K	Buy	+12,690	New	+$290K	﹤0.01%	1151

Other funds holding VYGR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Los Angeles Capital Management's VYGR Position: Q2 2026 in Review

Los Angeles Capital Management opened a new position in Voyager Therapeutics (VYGR) in Q2 2026: 37,180 shares worth $130K. The stake represents ﹤0.01% of the portfolio and ranks #1283 among its holdings. This is a return to the name: Los Angeles Capital Management previously reported a position in VYGR as recently as Q2 2025.

Los Angeles Capital Management first reported a position in VYGR in Q2 2019 and has held it in 10 quarters since. The position peaked at $1.52M in Q2 2020. 135 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

Los Angeles Capital Management held 37,180 shares of Voyager Therapeutics worth $130K as of Q2 2026.
Voyager Therapeutics was a new Los Angeles Capital Management position in Q2 2026.
Voyager Therapeutics made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #1283 holding.
Los Angeles Capital Management first reported a position in Voyager Therapeutics in Q2 2019 and has held it in 10 quarters since.
Los Angeles Capital Management's Voyager Therapeutics position peaked at $1.52M in Q2 2020.
135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.